REDUCTION OF DOXORUBICIN CARDIOTOXICITY BY PROLONGED CONTINUOUS INTRAVENOUS-INFUSION

被引：660

作者：

LEGHA, SS

BENJAMIN, RS

MACKAY, B

EWER, M

WALLACE, S

VALDIVIESO, M

RASMUSSEN, SL

BLUMENSCHEIN, GR

FREIREICH, EJ

机构：

[1] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, CTR CANC, DEPT PATHOL, HOUSTON, TX 77030 USA

[2] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, CTR CANC, DEPT MED, HOUSTON, TX 77030 USA

[3] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, CTR CANC, DEPT RADIOL, HOUSTON, TX 77030 USA

[4] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, CTR CANC, DEPT BIOMATH, HOUSTON, TX 77030 USA

来源：

关键词：

D O I：

10.7326/0003-4819-96-2-133

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：133 / 139

页数：7

共 33 条

[21] 2-2
[22] LEGHA SS, 1980, CANCER CLIN TRIALS, V3, P111
[23] TECHNIQUES FOR RIGHT AND LEFT-VENTRICULAR ENDOMYOCARDIAL BIOPSY
MASON, JW
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (05) : 887 - 892
[24] MINOW RA, 1977, CANCER, V39, P1397, DOI 10.1002/1097-0142(197704)39:4<1397::AID-CNCR2820390407>3.0.CO
[25] 2-U
[26] ADRIAMYCIN - ROLE OF LIPID PEROXIDATION IN CARDIAC TOXICITY AND TUMOR RESPONSE
MYERS, CE
MCGUIRE, WP
LISS, RH
IFRIM, I
GROTZINGER, K
YOUNG, RC
[J]. SCIENCE, 1977, 197 (4299) : 165 - 167
[27] PACCIARINI MA, 1978, CANCER TREAT REP, V62, P791
[28] RITCHIE JL, 1980, CANCER, V46, P1109, DOI 10.1002/1097-0142(19800901)46:5<1109::AID-CNCR2820460506>3.0.CO
[29] 2-B
[30] RISK-FACTORS FOR DOXORUBICIN-INDUCED CONGESTIVE HEART-FAILURE
VONHOFF, DD
LAYARD, MW
BASA, P
DAVIS, HL
VONHOFF, AL
ROZENCWEIG, M
MUGGIA, FM
[J]. ANNALS OF INTERNAL MEDICINE, 1979, 91 (05) : 710 - 717